Pulmonx Announces Inducement Grants under Nasdaq Listing Rul

REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that

Related Keywords

Pulmonx Zephyr , Mehul Joshi , Brian Johnston , Gilmartin Group , Pulmonx Corporation , Pulmonx Corporation Nasdaq , Compensation Committee , Chief Financial Officer , Nasdaq Listing Rule , Incentive Plan , Endobronchial Valve , Pulmonary Assessment System , Lung Analysis Platform , Zephyr Valve , Zephyr Valves , Region ,